• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Subsidiary 3: Medical 3D BioPrinting – M3DP

SUBSIDIARY #3

Medical 3D BioPrinting 

M3DP

http://pharmaceuticalintelligence.com/medical-3d-printing/

HQS – Boston, MA

HQS – Lausanne, Switzerland

  • Ontology Building for Medical 3D Printing: The Team @ Leaders in Pharmaceutical Business Intelligence (LPBI)
  • Cardiovascular Applications of 3D BioPrinting

Using 3D printed models for planning and guidance during endovascular intervention (VIDEO)

 VIEW VIDEO

http://www.3dbioprintingconference.com/surgery/using-3d-printed-models-for-planning-and-guidance-during-endovascular-intervention-video/

Bioprinted Valves That Grow: How 3D Printing is Transforming Heart Surgery (VIDEO)

VIEW VIDEO

http://www.3dbioprintingconference.com/3d-bioprinting/bioprinted-valves-that-grow-how-3d-printing-is-transforming-heart-surgery/

Matrix Organization

http://pharmaceuticalintelligence.com/2015/08/26/lpbis-m3dp-matrix-organization/

Repository of Resources on M3DP

http://pharmaceuticalintelligence.com/2015/08/18/repository-for-lpbis-initiative-on-medical-3d-printing/

HQS – Boston, MA – Aviva Lev-Ari, PhD, RN, Interim COO

HQS – Lausanne, Switzerland – Gerard Loiseau, ESQ – Strategic Planning & Departmental Finance

  • Applications in 3D BioPrinting

http://pharmaceuticalintelligence.com/2015/08/15/twelve-lecture-series-on-medical-3d-printing-applications-technologies-by-lpbis-medical-3d-printing-team/

  • Product Concept  – Dr. Pearlman

  1. StopMI
  2. Robotic Glove
  • BioMEMS

We are seeking a Private Equity Investor interested in Medical 3D BioPrinting to invest for an Equity position and provide Business Development and Finance capabilities to a Technical Team of Scientists (PhDs, MD/PhDs) and BioEngineers in Tissue Engineering, Pharmaceutical and Medical Devices (Cardiovascular and Orthopedic) using 3D BioPrinting.

  • Seeking $20Million for three Departments

Like this:

Like Loading...

This page has the following sub pages.

  • TEAM PRESENTATIONS: 8/2015 – 12/2015
  • BioMEMS – TEAM PRESENTATIONS 1/4/2016 – 3/31/2016

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,056 other subscribers
  • Recent Posts

    • Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983. January 31, 2026
    • 2026 World Economic Forum, 1/19 – 1/23/2026, Davos, Switzerland, LPBI Group’s KOLs interpretation of AI in Health Videos January 24, 2026
    • Evolving LPBI Group’s Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality January 12, 2026
    • Aviva Lev-Ari, PhD, RN – Biography ->> Grokepedia Entry January 11, 2026
    • List of Articles included in the Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com January 10, 2026
    • The youngest leader in AI in Health: Tanishq Mathew Abraham, Ph.D. (@iScienceLuvr) January 8, 2026
    • 2026 Grok Multimodal Causal Reasoning on Proprietary Cariovascular Corpus: From 2021 Wolfram NLP Baseline to Thousands of Novel Relationships – A Second Head-to-Head Validation of LPBI’s Domain-Aware Training Advantage January 6, 2026
    • Workflow for Dynamic Linkage and Transition between two Authoring Systems: LPBI Group’s WordPress.com Multi-Authors Authoring System and Microsoft PowerPoint product for Slide show presentation – Part 10.1 in Composition of Methods January 6, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d